Correlation Between Pulmatrix and Gyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Gyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Gyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Gyre Therapeutics, you can compare the effects of market volatilities on Pulmatrix and Gyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Gyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Gyre Therapeutics.

Diversification Opportunities for Pulmatrix and Gyre Therapeutics

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pulmatrix and Gyre is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Gyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gyre Therapeutics and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Gyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gyre Therapeutics has no effect on the direction of Pulmatrix i.e., Pulmatrix and Gyre Therapeutics go up and down completely randomly.

Pair Corralation between Pulmatrix and Gyre Therapeutics

Given the investment horizon of 90 days Pulmatrix is expected to under-perform the Gyre Therapeutics. In addition to that, Pulmatrix is 1.04 times more volatile than Gyre Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. Gyre Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest  844.00  in Gyre Therapeutics on June 11, 2025 and sell it today you would lose (75.00) from holding Gyre Therapeutics or give up 8.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pulmatrix  vs.  Gyre Therapeutics

 Performance 
       Timeline  
Pulmatrix 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Pulmatrix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in October 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Gyre Therapeutics 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Gyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Gyre Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pulmatrix and Gyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pulmatrix and Gyre Therapeutics

The main advantage of trading using opposite Pulmatrix and Gyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Gyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gyre Therapeutics will offset losses from the drop in Gyre Therapeutics' long position.
The idea behind Pulmatrix and Gyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
CEOs Directory
Screen CEOs from public companies around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins